Standard Biotools (LAB) Cash from Investing Activities Growth (1y) (2011 - 2026)
Powered by 
Analysis
Standard Biotools (LAB) Cash from Investing Activities Growth (1y) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 225.48 Bn | 221.41 Bn | 8.34 Bn | 156.94% |
| 2 | Danaher | 144.42 Bn | 140.08 Bn | 3.61 Bn | -3,832.95% |
| 3 | Agilent Technologies | 40.86 Bn | 39.11 Bn | 1.04 Bn | -975.00% |
| 4 | Illumina | 30.97 Bn | 29.80 Bn | 770.00 Mn | -148.98% |
| 5 | Revvity | 13.85 Bn | 12.83 Bn | 416.87 Mn | 81.42% |
| 6 | Bio-Techne | 11.27 Bn | 11.01 Bn | 211.39 Mn | -1,838.18% |
| 7 | Bio-Rad Laboratories | 10.11 Bn | 8.49 Bn | 345.80 Mn | 42.20% |
| 8 | Repligen | 9.33 Bn | 8.31 Bn | 110.04 Mn | 73.35% |
| 9 | 10x Genomics | 8.77 Bn | 8.21 Bn | 112.50 Mn | -723.75% |
| 10 | Standard Biotools | 285.26 Mn | -191.45 Mn | 10.54 Mn | -47.62% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -47.62% |
| Mar 31, 2026 | 1,206.60% |
| Dec 31, 2025 | -131.25% |
| Sep 30, 2025 | 78.37% |
| Jun 30, 2025 | -45.27% |
| Mar 31, 2025 | -95.40% |
| Dec 31, 2024 | 296.13% |
| Sep 30, 2024 | 38.14% |
| Jun 30, 2024 | 25.25% |
| Mar 31, 2024 | 637.07% |
| Dec 31, 2023 | -132.59% |
| Sep 30, 2023 | -565.03% |
| Jun 30, 2023 | 129.03% |
| Mar 31, 2023 | 5,071.66% |
| Sep 30, 2022 | 199.40% |
| Jun 30, 2022 | -1,419.96% |
| Mar 31, 2022 | 82.37% |
| Sep 30, 2021 | -181.76% |
| Jun 30, 2021 | -189.82% |
| Mar 31, 2021 | -128.20% |